Search research articles
Contact Us
Filters
Showing results (21-30 of 221) with videos related to
Page
of 23
Sort By:
Biomarkers in Medicine
|
March 24, 2018
Biomarker use in lung cancer management: expanding horizons
Jason E Sandler, Meghan Kaumaya, Balazs Halmos
Journal of Thoracic Disease
|
July 10, 2019
Changes in store for early-stage non-small cell lung cancer
Jason E Sandler, Angelica D'Aiello, Balazs Halmos
Cancer Cell
|
June 18, 2026
Targeting drug-tolerant persister cells: Let's bring on the TROPs!
Motohiro Izumi, Susumu S Kobayashi, Balazs Halmos
Clinical Lung Cancer
|
April 30, 2026
To Stop or Not to Stop: Is It Time to Reevaluate Immunotherapy Duration in Advanced/Metastatic NSCLC?
Matthew Lee, Shuai Wang, Lova Sun, et al.
Journal of Thoracic Disease
|
October 22, 2019
Local consolidative therapy in metastatic non-small cell lung cancer
Gunj Patel, Balazs Halmos, Haiying Cheng, et al.
Annals of Translational Medicine
|
February 7, 2017
MET/HGF pathway activation as a paradigm of resistance to targeted therapies
Brian Ko, Tianfang He, Shirish Gadgeel, et al.
The Oncologist
|
May 27, 2025
Thoracic SMARCA4-deficient undifferentiated tumor: diagnostic characteristics, molecular insights, and treatment approaches
Junmin Song, Adam Gersten, Benjamin Herzberg, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 17, 2013
Update in lung cancer and mesothelioma 2012
Charles A Powell, Balazs Halmos, Serge P Nana-Sinkam
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2008
Dysregulation of the C/EBPalpha differentiation pathway in human cancer
Steffen Koschmieder, Balazs Halmos, Elena Levantini, et al.
Journal of Geriatric Oncology
|
July 10, 2023
Cancer rarely travels alone: Addressing the accumulation of risk and early mortality for older adults with advanced lung cancer
Carolyn J Presley, Megan Baumgart, Balazs Halmos, et al.
Page
of 23
Search research articles
Search
Showing results (21-30 of 221) with videos related to
Sort By:
Page
of 23
Biomarkers in Medicine
|
March 24, 2018
Biomarker use in lung cancer management: expanding horizons
Jason E Sandler, Meghan Kaumaya, Balazs Halmos
Journal of Thoracic Disease
|
July 10, 2019
Changes in store for early-stage non-small cell lung cancer
Jason E Sandler, Angelica D'Aiello, Balazs Halmos
Cancer Cell
|
June 18, 2026
Targeting drug-tolerant persister cells: Let's bring on the TROPs!
Motohiro Izumi, Susumu S Kobayashi, Balazs Halmos
Clinical Lung Cancer
|
April 30, 2026
To Stop or Not to Stop: Is It Time to Reevaluate Immunotherapy Duration in Advanced/Metastatic NSCLC?
Matthew Lee, Shuai Wang, Lova Sun, et al.
Journal of Thoracic Disease
|
October 22, 2019
Local consolidative therapy in metastatic non-small cell lung cancer
Gunj Patel, Balazs Halmos, Haiying Cheng, et al.
Annals of Translational Medicine
|
February 7, 2017
MET/HGF pathway activation as a paradigm of resistance to targeted therapies
Brian Ko, Tianfang He, Shirish Gadgeel, et al.
The Oncologist
|
May 27, 2025
Thoracic SMARCA4-deficient undifferentiated tumor: diagnostic characteristics, molecular insights, and treatment approaches
Junmin Song, Adam Gersten, Benjamin Herzberg, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 17, 2013
Update in lung cancer and mesothelioma 2012
Charles A Powell, Balazs Halmos, Serge P Nana-Sinkam
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2008
Dysregulation of the C/EBPalpha differentiation pathway in human cancer
Steffen Koschmieder, Balazs Halmos, Elena Levantini, et al.
Journal of Geriatric Oncology
|
July 10, 2023
Cancer rarely travels alone: Addressing the accumulation of risk and early mortality for older adults with advanced lung cancer
Carolyn J Presley, Megan Baumgart, Balazs Halmos, et al.
Page
of 23